sTNF-RII: Is it useful for the early diagnosis of rejection and for prognosis after renal transplantation?

Transplant International

Volumn 15, Issue 7, 2002, Pages 335-340

  Diller, Ricarda ^a   Winde, Günther ^a   Kötting, Sonja ^a   Senninger, Norbert ^a   Dietl, Karl Heinz ^a   Spiegel, Hans Ullrich ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Kidney transplantation; Prognostic factors; Soluble TNF receptors; STNF RII; Transplant rejection

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; GRAFT REJECTION; HIGH RISK PATIENT; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LABORATORY TEST; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; RISK ASSESSMENT; SEPSIS; URINALYSIS; URINE LEVEL;

ANTIGENS, CD; BIOLOGICAL MARKERS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0036933561     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00175.x     Document Type: Article

References (37)

1. Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Bruining HA, Otto C, Tobin E, Zwingelstein C, Leslauer W, Leighton A (1997) p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study group. JAMA 277:1531-1538
2. Baumgartner JD, Calandra T (1999) Treatment of sepsis: past and future avenues. Drugs 75:127-132
3. Bemelman FJ, Jansen J, van der Poll T, van Deventer SJH, ten Berge RJM (1994) Increase of sTNF receptor levels in acute renal allograft rejection after treatment with OKT3. Nephrol Dial Transplant 9:1786-1790
4. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer WM Loetscher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131
5. Cope AP, Aderka D, Wallach D, Kahan M, Chu NR, Brennan FM, Feldmann M (1995) Soluble TNF receptor production by activated T-lymphocytes: differential effects of acute and chronic exposure to TNF. Immunology 84:21-30
6. Corey HE, Alfonso F, Hamele-Bena D, Greenstein SM, Schechner R, Tellis V, Geva P, Koss LG (1997) Urine cytology and the diagnosis of renal allograft rejection. II. Studies using immunostaining. Acta Cytol 41:1742-1746
7. Corti A, Poiesi C, Merli S, Cassani G (1994) Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay: effects of TNF alpha-soluble TNF receptor (p55) complex dissociation during assay incubations. J Immunol Methods 177:191-198
8. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D (1995) Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 54:1-8
9. Dörge SE, Roux-Lombard P, Dayer JM, Koch KM, Frei U, Lonnemann G (1994) Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. Transplantation 58:1000-1008
10. Durez P, Appelboom T, Pira C, Stordeur P, Vray B, Golman M (1999) Antiinflammatory properties of mycophenolate mofetil in murine endotoxinemia: inhibition of TNF-α and upregulation of I1-10 release. Int J Immunopharmacol 21:581-587
11. Eason JD, Wee S, Kawai T, Hong HZ, Powelson JA, Widmer MB, Cosimi AB (1995) Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumour necrosis factor receptors. Transplantation 59:300-305
12. Engelberts I, Moeller A, Schoen GJM, Van der Linde CJ, Buurman WA (1991) Evaluation of measurement of human TNF α in plasma by ELISA. Lymphokine Cytokine Res 10:69-76
13. Fisher CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RMH, Benjamin E (1996) Treatment of septic shock with the tumour necrosis factor receptor: Fc fusion protein. N Engl J Med 334:1697-1702
14. Flach R, Speidel N, Flohé S, Börgermann J, Dresen IG, Erhard J, Schade FU (1998) Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR. Cytokine 10:445-451
15. George JF, Kirklin JK, Naftel DC, Bourge RC, White-Williams C, McGiffin DC, Savunen T, Everson MP (1997) Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients. J Heart Lung Transplant 16:1046-1053
16. Halloran PF, Cockfield SM, Madrenas J (1989) The mediators of inflammation (interleukin 1, Interferon-γ and tumor necrosis factor) and their relevance to rejection. Transplant Proc 21:26-30
17. Halwachs G, Tiran A, Reisinger EC, Zach R, Sabin K, Folsch B, Lanzer H, Holzer H, Wilders-Truschnig M (1994) Serum levels of soluble receptor for tumor necrosis factor in patients with renal disease. Clin Invest 72:473-476
18. Herbelin A, Chatenoud L, Roux-Lombard P, De Groote D, Legendre C, Dayer JM, Descamps-Latscha B, Kreis H, Bach JF (1995) In vivo soluble tumor necrosis factor receptor release in OKT3 treated patients. Transplantation 59:1470-1475
19. Hoffmann MW, Wonigeit K, Steinhoff G, Herzbeck H, Flach H, Pichlmayr R (1993) Production of cytokines (TNF-alpha, I1-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation 55:329-335
20. Jeyarajah DR, Kadakia RA, O'Toole K, Newell KA, Josephson MA, Spargo BH, Woodle ES, Thistlethwaite JR Jr (1995) Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal rejection. Transplant Proc 25:887-889
21. Kasai T, Inada K, Takakuwa T, Yamada Y, Inoue Y, Shimamura T, Taniguchi S, Sato S, Wakabayashi G, Endo S (1997) Anti-inflammatory cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 98:34-42
22. Keil M, Pec MK, Schenn G, Grunberger T, Kramer G, Fugger R, Steininger R, Mühlbacher F, Balcke P, Stockenhuber F (1994) Value of serum tumour necrosis factor concentrations in the diagnosis and prognosis of renal graft rejection. Nephrol Dial Transplant 9:815-819
23. Lambert C, Berthoux P, Vindimian M, Berthoux F (1994) Natural serum TNF antagonists in end stage renal failure and following renal transplantation. Nephrol Dial Transplant 9:1791-1796
24. Le Boeuf RC, Schreyer SA (1998) The role of tumor necrosis factor-α receptors in atherosclerosis. Trends Cardiovasc Med 8:131-138
25. Leeuwenberg JFM, Froon AHM, Vaessen LMB, Hoitsma AJ, Abramowicz D, van Hooff JP, Buurman WA (1995) Soluble tumor necrosis factor-receptors are not a useful marker of acute allograft rejection: a study in patients with renal or cardiac allografts. Transpl Int 8:459-465
26. Maury CPJ, Teppo AM (1987) Raised serum levels of cachectin/tumor necrosis factor α in renal allograft rejection. J Exp Med 166:1132-1137
27. Mueller AR, Platz KP, Haak M, Undi H, Müller C, Kottgen E, Weidemann H, Neuhaus P (1996) The release of cytokines, adhesion molecules and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation 62:1118-1126
28. Newstead CG, Lamb WR, Brenchley PE, Short CD (1993) Serum and urine I1-6 and TNF-alpha in renal transplant recipients. Transplantation 56:831-835
29. Olive C, Cheung C, Falk MC (1999) Apoptosis and expression of cytotoxic T lymphocyte effector molecules in renal allograft. Transpl Immunol 7:27-36
30. Opal SM, Cross AS (1999) Clinical trials for severe sepsis. Past failures, and future hopes. Infect Dis Clin North Am 13:285-297
31. Platz KP, Mueller AR, Rossaint R, Steinmüller T, Lemmens HP, Lobeck H, Neuhaus P (1996) Cytokine pattern during rejection and infection after liver transplantation - improvements in postoperative monitoring? Transplantation 62:1441-1450
32. Salom RN, Maguire JA, Hancock WW (1998) Endothelial activation and cytokine expression in human acute cardiac allograft rejection. Pathology 30:24-29
33. Scales WE, Campbell DA, Green ME, Rewick DG (1994) Hepatic ischemia/reperfusion injury: importance of oxidant/tumor necrosis factor interactions. Am J Physiol 267:G1122-1127
34. Sprang SR (1990) The divergent receptors for TNF. Trends Biochem Sci 15:366-368
35. Strom TB, Roy-Chaydhury P, Manfro R, Zheng XX, Nickerson PW, Wood K, Bushell A (1996) The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 8:688-693
36. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Immunology 88:9292-9296
37. Thorsby E (1997) Transplantation immunology: a brief update. Transplant Proc 29:3129-3134